Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC
Clinical trial NCT05993858 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05993858
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-20
- Primary completion
- 2025-12-20
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.